tiprankstipranks
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
Holding BBIO?
Track your performance easily

BridgeBio Pharma (BBIO) Ownership - Who Owns BridgeBio Pharma?

1,106 Followers

BridgeBio Pharma (BBIO) Ownership Overview

20.77%15.72%46.04%13.72%3.75%
20.77% Insiders
46.04% Other Institutional Investors
13.72% ETFs
3.75% Public Companies and
Individual Investors
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail, and individual investors. Approximately 75.48% of the company’s stock is owned by Institutional Investors, 20.77% is owned by Insiders, and 3.75% is owned by Public Companies and Individual Investors.
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail, and individual investors. Approximately 61.76% of the company’s stock is owned by Institutional Investors, 20.77% is owned by Insiders, and 13.72% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 17, 2024
xxxxxxxxxxxxx
$149350000
Feb 13, 2024
xxxxxxxxxxxxx
$44476

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
25,260,971Insider13.37%693,161,044
25,120,991Institution13.29%689,319,993
13,436,470Institution7.11%368,696,737
12,219,800Institution6.47%335,311,312
9,959,504Insider5.59%273,288,790
7,482,850Institution3.96%205,329,404
6,068,125Institution3.21%166,509,350
3,158,625Institution1.67%86,672,670
1,747,000Institution0.92%47,937,680
1,710,481Institution0.91%46,935,599

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
12,219,800Institution6.47%335,311,312
1,710,481Institution0.91%46,935,599
1,595,729Institution0.84%43,786,804
1,548,577Institution0.82%42,492,953
1,490,722Institution0.79%40,905,412
802,299Institution0.42%22,015,085
802,019Institution0.42%22,007,401
787,327Institution0.42%21,604,253
699,643Institution0.37%19,198,204
673,688Institution0.36%18,485,999

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,505,565Institution2.38%105,475,277
3,778,859Institution2.00%103,691,891
3,535,986Institution1.87%82,777,432
2,883,765Institution1.53%78,784,460
2,195,265Institution1.16%51,391,154
1,943,824Institution1.03%45,504,920
963,611Institution0.51%26,441,486
804,316Institution0.43%22,070,431
712,895Institution0.38%19,476,291
578,628Institution0.31%15,808,117

FAQ

Who Owns BridgeBio Pharma Inc (BBIO)?
According to the latest TipRanks data, approximately 46.04% of the company's stock is held by institutional investors, 20.77% is held by insiders, and 3.75% is held by retail investors.
    What percentage of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 46.04% of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors.
      What percentage of BridgeBio Pharma Inc (BBIO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 3.75% of BridgeBio Pharma Inc (BBIO) stock is held by retail investors.
        Who owns the most shares of BridgeBio Pharma Inc (BBIO)?
        KKR Genetic Disorder L.P. owns the most shares of BridgeBio Pharma Inc (BBIO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis